
Twist Bioscience
Twist Bioscience: A leading US biotech firm specializing in synthetic DNA for diverse applications.
- 989
- Public company
- San Francisco, CA, USUnited States

Twist Bioscience: A leading US biotech firm specializing in synthetic DNA for diverse applications.
twistbioscience.comCrawled Oct 16, 2026
Short article introducing two case studies, one using Pan-Viral panel and another for Antibody Discovery for Infectious Disease.
The study from KU Leuven compares indoor air and citywide wastewater monitoring using the Twist Comprehensive Viral Research Panel. It reports that hybrid-capture metagenomics identifies hundreds of viral species across environmental sample types.
The page discusses how next-generation sequencing can reduce sequencing costs and help investigators and clinicians characterize genetic makeup. It also describes protocol evaluation and optimization to balance data quality and cost.
The technote compares Twist’s Exome 2.0 panels with four commercially available panels from other vendors and notes that targeted exome panels can differ in performance and miss data needed for experiments.
Twist Bioscience is a synthetic biology company that makes gene synthesis, oligo pools, exome, NGS target enrichment, variant libraries, and other synthetic DNA tools.
These terms went into effect on February 8, 2017 and were last updated January 1, 2020
Anthropic’s AI model, Claude, designed 211 protein minibinders targeting five scorpion neurotoxins from four species (Mexico, Brazil, North Africa, Middle East). Using 12 design tools, Claude autonomously generated 318,484 designs in 64 hours, filtering for novelty and binding potential. Lab testing by Adaptyv Bio and Twist Bioscience confirmed 17 binders meeting criteria, though none neutralized venom in cellular tests. The designs aim to accelerate development of affordable antivenoms for neglected tropical diseases, where traditional antibody-based treatments are costly and limited in scope. All designs and data are publicly released for further research.
Oct 2026AnthropicNews article